UK markets open in 2 hours 17 minutes
NIKKEI 225
38,258.77 -15.28 (-0.04%) HANG SENG
18,155.28 +392.25 (+2.21%) CRUDE OIL
79.52 +0.52 (+0.66%) GOLD FUTURES
2,329.30 +18.30 (+0.79%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,847.54 -2,144.63 (-4.47%)
Bellerophon Therapeutics, Inc. (0HMP.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 02:30PM BST
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.68 |
| 52-week change 3 | -99.20% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 12.3500 |
| 52-week low 3 | 0.0000 |
| 50-day moving average 3 | 0.2924 |
| 200-day moving average 3 | 3.5448 |
Share statistics
| Avg vol (3-month) 3 | 21.22k |
| Avg vol (10-day) 3 | 22.84k |
| Shares outstanding 5 | N/A |
| Implied shares outstanding 6 | N/A |
| Float 8 | 10.2M |
| % held by insiders 1 | 15.03% |
| % held by institutions 1 | 10.39% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | N/A |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 0.066667:1 |
| Last split date 3 | 10 Feb 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | -164.06% |
| Operating margin (ttm) | -195.76% |
Management effectiveness
| Return on assets (ttm) | -78.47% |
| Return on equity (ttm) | -165.96% |
Income statement
| Revenue (ttm) | 5.64M |
| Revenue per share (ttm) | 0.51 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -11.04M |
| Net income avi to common (ttm) | -9.25M |
| Diluted EPS (ttm) | -1.8850 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.38M |
| Total cash per share (mrq) | 0.36 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 3.96 |
| Book value per share (mrq) | 0.30 |
Cash flow statement
| Operating cash flow (ttm) | -12.34M |
| Levered free cash flow (ttm) | -9.7M |
© 2024 Yahoo. All rights reserved.